NewsFlashAnzeige
Mit weltweiten Goldminen-Aktien überproportional vom Goldpreis profitieren

Chart

Neuigkeiten

ZeitTitel
SmartbrokerSmartbroker: Ab 0€ pro Order handeln mit dem Testsieger (Finanztest 11/2020) Anzeige
29.12.20
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
06.11.20
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
06.10.20
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
03.09.20
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
30.07.20
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
19.06.20
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
12.06.20
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
09.06.20
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
02.06.20
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
07.05.20
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
04.05.20
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
27.04.20
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
13.04.20
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
09.04.20
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Branchen News: Pharmaindustrie

ZeitTitel
01:58 Uhr
MedMen Announces Investment from AWH into MedMen’s New York Operations
00:05 Uhr
Quanterix’ Kevin Hrusovsky to Present at the Cowen 41st Annual Health Care Conference on March 3 and Appear on the Feb. 26 Episode of the Health Care Rounds Podcast
25.02.21
USA: Biontech-Impfstoff darf in normalem Gefrierfach gelagert werden
25.02.21
Arcutis to Present at the Cowen 41st Annual Health Care Conference
25.02.21
Biden: USA sind selbstgesteckten Impfzielen um 'Wochen' voraus
mehr Branchennachrichten »

Aktienkurs

BörsenplatzNasdaq
Letzter Kurs17,890USD
Performance-2,51 %
Kurszeit02:00:00
Eröffnung17,610USD
Tageshoch18,450USD
Tagestief17,610USD
Vortageskurs18,350USD
Volumen131,90 Tsd.Stk.
52-Wochen Hoch22,690USD
52-Wochen Tief12,325USD
Anzahl Trades684
Performance 1 Monat-4,97 %
Performance 1 Jahr+1,08 %

Stammdaten

NameAmphastar Pharmaceuticals Inc
KurznameAmphastar Pharma
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA11664
SymbolAMPH
BranchePharmaindustrie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl47,50 Mio.
Marktkapitalisierung849,85 Mio.USD

Performance

ZeitKursPerf.
1 Tag17,890USD
-2,51 %
1 Woche18,700USD
-4,97 %
1 Monat18,700USD
-4,97 %
3 Monate18,010USD
-1,33 %
6 Monate20,120USD
-11,68 %
Lfd. Jahr20,110USD
-11,64 %
1 Jahr17,580USD
+1,08 %
3 Jahre19,200USD
-7,45 %
5 Jahre11,200USD
+58,66 %
mehr Performancedaten »

Kontaktdaten

NameAmphastar Pharmaceuticals Inc
StadtRancho Cucamonga, CA
LandUSA USA
Webseitewww.amphastar.com

Aktionäre interessieren sich auch für:

#WertpapierPerf. %
1.
Ferrellgas Partners
-1,64
2.
Sangamo Therapeutics
-10,62
3.
Centene
-0,99
4.
Provident Financial
-2,94
5.
Athabasca Oil
-6,38
6.
Alto Ingredients
+8,16
7.
Weatherford International
-12,17
8.
exactEarth
-5,47
9.
Eldorado Gold
-5,86
10.
CGI Registered (A)
-0,46

Emission

Emissionspreis7,000USD
Emissionsvolumen8.000.000Stück
ZeichnungsgebührNein
IPO Anmeldetag19.05.2014
IPO25.06.2014
PlatzierungÖffentlich